Concepedia

Lionel Arlettaz

LA

6

Publications

343

Citations

6

H-Index

1999

Active since

Affiliations

University Hospital of Geneva(Current)

Louis-Jeantet Foundation

Lionel Arlettaz is an author at University Hospital of Geneva specializing in cell signaling, immunology, and t cell immunity.

Top concepts

Publications per year

1999–2020

6

Publications

6

Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors

Valérie Bigouret, Till Hoffmann, Lionel Arlettaz et al. · Blood · 2003 · 93 citations · Full text

CD45 isoform phenotypes of human T cells: CD4+CD45RA–RO+ memory T cells re-acquire CD45RA without losing CD45RO

Lionel Arlettaz, Catherine Barbey, Florence Dumont-Girard et al. · European Journal of Immunology · 1999 · 67 citations

Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8<sup>+</sup> TCR αβ lymphocytes

Lionel Arlettaz, Jean Villard, Casimir de Rham et al. · European Journal of Immunology · 2004 · 66 citations · Full text

, , +14

Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications

Yves Chalandon, Sylvie Degermann, Jean Villard et al. · Blood · 2005 · 54 citations · Full text

Expression of inhibitory KIR is confined to CD8<sup>+</sup> effector T cells and limits their proliferative capacity

Lionel Arlettaz, Sylvie Degermann, Casimir de Rham et al. · European Journal of Immunology · 2004 · 39 citations

Rows per page

1–5 of 6